Plus Therapeutics, Inc. (PSTV)
0.6722
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 16:00
0.6555
-0.02
(-2.48%)
After-Hours: 05:23
Plus Therapeutics Cash from Investing (Quarterly): 1.297M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 13.99M |
| Xtant Medical Holdings, Inc. | 4.679M |
| VolitionRX Ltd. | 0.0012M |
| Catheter Precision, Inc. | -0.028M |
| Picard Medical, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.548M |
| Cash from Financing (Quarterly) | 12.31M |
| Free Cash Flow | -15.78M |
| Free Cash Flow Per Share (Quarterly) | -0.024 |
| Free Cash Flow to Equity (Quarterly) | -2.573M |
| Free Cash Flow to Firm (Quarterly) | -2.582M |
| Free Cash Flow Yield | -27.87% |